EN ISO 14160:2011
Superseded
View Superseded by
Sterilization of health care products - Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives - Requirements for characterization, development, validation and routine control of a sterilization process for medical devices (ISO 14160:2011)
01-07-2011
08-07-2021
Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 Quality management system elements
5 Sterilizing agent characterization
6 Process and equipment characterization
7 Product definition
8 Process definition
9 Validation
10 Routine monitoring and control
11 Product release from sterilization
12 Maintaining process effectiveness
Annex A (informative) - Guidance for the application of this
International Standard
Annex B (normative) - Determination of lethal rate of the
sterilization process
Annex C (informative) - Flowchart for microbicidal effectiveness,
process definition, and microbiological performance
qualification
Bibliography
Annex ZA (informative) - Relationship between this European
Standard and the Essential Requirements of EU Directive
93/42/EEC on Medical Devices
ISO 14160:2011 specifies requirements for the characterization of a liquid chemical sterilizing agent and for the development, validation, process control and monitoring of sterilization by liquid chemical sterilizing agents of single-use medical devices comprising, in whole or in part, materials of animal origin.ISO 14160:2011 covers the control of risks arising from contamination with bacteria and fungi by application of a liquid chemical sterilization process. Risks associated with other microorganisms need to be assessed. ISO 14160:2011 is not applicable to material of human origin.ISO 14160:2011 does not describe methods for the validation of the inactivation of viruses and transmissible spongiform encephalopath (TSE) agents. ISO 14160:2011 does not describe methods for validation of the inactivation, elimination, or elimination and inactivation of protozoa and parasites.The requirements for validation and routine control described in ISO 14160:2011 are only applicable to the defined sterilization process of a medical device, which is performed after the manufacturing process, and do not take account of the lethal effects of other bioburden reduction steps.ISO 14160:2011 does not specify tests to establish the effects of any chosen sterilization method upon the fitness for use of the medical device.ISO 14160:2011 does not cover the level of residual sterilizing agent within medical devices.ISO 14160:2011 does not describe a quality management system for the control of all stages of manufacture.
| Committee |
CEN/TC 204
|
| DevelopmentNote |
Supersedes PREN ISO 14160. (08/2011)
|
| DocumentType |
Standard
|
| PublisherName |
Comite Europeen de Normalisation
|
| Status |
Superseded
|
| SupersededBy | |
| Supersedes |
| Standards | Relationship |
| BS EN ISO 14160:2011 | Identical |
| NBN EN ISO 14160 : 2011 | Identical |
| I.S. EN ISO 14160:2011 | Identical |
| DIN EN ISO 14160:2011-10 | Identical |
| NS EN ISO 14160 : 2011 | Identical |
| NF EN ISO 14160 : 2011 | Identical |
| SS-EN ISO 14160:2011 | Identical |
| NEN EN ISO 14160 : 2011 | Identical |
| PN EN ISO 14160 : 2013 | Identical |
| ISO 14160:2011 | Identical |
| UNE-EN ISO 14160:2012 | Identical |